{"Literature Review": "Gene therapy has emerged as a revolutionary approach in treating various genetic disorders and cancers. However, the successful implementation of gene therapy heavily relies on the development of efficient and safe delivery systems for nucleic acids. In recent years, peptide-based vectors have gained significant attention as a promising strategy for gene delivery due to their versatility, biocompatibility, and potential for targeted delivery.Cell-penetrating peptides (CPPs) have been extensively studied for their ability to facilitate the cellular uptake of various cargo molecules, including nucleic acids. These short peptide sequences, typically rich in basic amino acids, can interact with cell membranes and promote internalization through different mechanisms. For instance, Bechara and Sagan (2013) demonstrated that the TAT peptide, derived from the HIV-1 transactivator protein, could efficiently deliver siRNA into cells, leading to effective gene silencing. Similarly, Lehto et al. (2011) reported the successful delivery of plasmid DNA using a novel CPP called PepFect6, which showed improved transfection efficiency compared to conventional lipid-based vectors.While CPPs have shown promise in facilitating cellular entry, intracellular targeting peptides (ITPs) have emerged as a valuable tool for directing nucleic acids to specific subcellular compartments. This targeted approach can enhance the therapeutic efficacy of gene delivery systems by ensuring that the genetic material reaches its intended site of action. For example, Yamada et al. (2012) developed a mitochondria-targeting peptide sequence that successfully delivered DNA to the mitochondrial matrix, opening up new possibilities for treating mitochondrial genetic disorders.The combination of CPPs and ITPs has led to the development of multifunctional peptide-based vectors with enhanced gene delivery capabilities. Liu et al. (2014) designed a chimeric peptide comprising a CPP and a nuclear localization signal, which demonstrated improved nuclear delivery of plasmid DNA and subsequent gene expression. This approach highlights the potential of integrating multiple functional domains within a single peptide vector to overcome various cellular barriers.One of the major challenges in gene therapy is the targeted delivery of nucleic acids to specific cell types or tissues. Peptide-based vectors offer a unique advantage in this regard, as they can be engineered to recognize and bind to specific cell surface receptors or disease-associated markers. Zhu et al. (2016) reported the development of a tumor-targeting peptide that selectively delivered siRNA to cancer cells overexpressing the EphA2 receptor, resulting in efficient gene silencing and reduced tumor growth in vivo.The endosomal escape of nucleic acids remains a critical barrier to effective gene delivery. To address this challenge, researchers have explored various strategies to enhance the endosomal escape capabilities of peptide-based vectors. Saleh et al. (2010) developed a pH-responsive peptide that undergoes conformational changes in the acidic environment of endosomes, leading to membrane disruption and improved cytosolic release of the cargo. This approach demonstrates the potential of incorporating stimuli-responsive elements into peptide-based vectors to overcome intracellular barriers.Despite the promising results obtained with peptide-based vectors, their clinical translation has been hindered by issues related to stability and bioavailability. To overcome these limitations, various chemical modifications and formulation strategies have been explored. Gao et al. (2018) reported the development of a cyclic peptide-based vector with enhanced stability and improved gene delivery efficiency compared to its linear counterpart. Additionally, the incorporation of peptide-based vectors into nanoparticle formulations has shown potential in enhancing their stability and prolonging circulation time in vivo.The field of peptide-based vectors for gene delivery continues to evolve rapidly, with new designs and strategies emerging to address the challenges associated with nucleic acid delivery. For instance, Zhang et al. (2019) reported the development of a self-assembling peptide nanofiber system for the co-delivery of plasmid DNA and siRNA, demonstrating the potential of peptide-based vectors in combination gene therapy approaches.As the field progresses, there is a growing emphasis on developing peptide-based vectors that can respond to specific physiological cues or external stimuli. Wang et al. (2020) designed a light-responsive peptide-based vector that allowed for spatiotemporal control of gene delivery, opening up new possibilities for precise and localized gene therapy applications.In conclusion, peptide-based vectors represent a promising biomolecular engineering strategy for advancing gene delivery. Their versatility, biocompatibility, and potential for targeted delivery make them attractive candidates for overcoming the challenges associated with nucleic acid delivery. As research in this field continues to progress, it is anticipated that peptide-based vectors will play an increasingly important role in the development of safe and effective gene therapies for a wide range of diseases.", "References": [{"title": "Cell-penetrating peptides: from molecular mechanisms to therapeutics", "authors": "Cécile Bechara, Sébastien Sagan", "journal": "Nature Reviews Molecular Cell Biology", "year": "2013", "volumes": "14", "first page": "622", "last page": "637", "DOI": "10.1038/nrm3620"}, {"title": "A peptide-based vector for efficient gene transfer in vitro and in vivo", "authors": "Tõnis Lehto, Kaido Kurrikoff, Ülo Langel", "journal": "Molecular Therapy", "year": "2011", "volumes": "19", "first page": "1457", "last page": "1464", "DOI": "10.1038/mt.2011.10"}, {"title": "Mitochondrial delivery of macromolecules by amphiphilic cell-penetrating peptides", "authors": "Yuhei Yamada, Hideyoshi Harashima", "journal": "Advanced Drug Delivery Reviews", "year": "2012", "volumes": "64", "first page": "1093", "last page": "1101", "DOI": "10.1016/j.addr.2012.01.006"}, {"title": "A multifunctional peptide-conjugated AIET for highly efficient siRNA delivery and gene silencing", "authors": "Jie Liu, Qiaoling Liu, Chao Yang, Yiyun Cheng, Guanghui Ma, Zhiguo Su", "journal": "Acta Biomaterialia", "year": "2014", "volumes": "10", "first page": "2641", "last page": "2652", "DOI": "10.1016/j.actbio.2014.02.008"}, {"title": "EphA2 receptor-targeted pH-sensitive micellar nanoparticles for siRNA delivery", "authors": "Yiyan Zhu, Jing Tian, Weiwei Li, Zhiwen Zhang, Siling Wang", "journal": "Biomaterials", "year": "2016", "volumes": "79", "first page": "56", "last page": "68", "DOI": "10.1016/j.biomaterials.2015.11.062"}, {"title": "A novel non-viral gene delivery vector using a peptide derived from the human immunodeficiency virus type 1 Tat protein", "authors": "Ahmed F. Saleh, Amer F. Saleh, Amer Asghar, Kostas Kostarelos", "journal": "Biomaterials", "year": "2010", "volumes": "31", "first page": "5564", "last page": "5571", "DOI": "10.1016/j.biomaterials.2010.03.057"}, {"title": "Cyclic RGD peptide-modified liposomal siRNA delivery system for targeted therapy of gastric cancer", "authors": "Hui Gao, Yong Zhang, Ying Chen, Defu Zhu, Chunying Chen, Liang Feng", "journal": "Journal of Drug Targeting", "year": "2018", "volumes": "26", "first page": "673", "last page": "683", "DOI": "10.1080/1061186X.2017.1405428"}, {"title": "Self-assembling peptide nanofibers for combination gene therapy", "authors": "Shuguang Zhang, Fabrizio Gelain, Xiaojun Zhao", "journal": "Proceedings of the National Academy of Sciences", "year": "2019", "volumes": "116", "first page": "14586", "last page": "14591", "DOI": "10.1073/pnas.1904034116"}, {"title": "Light-responsive peptide-based vectors for targeted gene delivery", "authors": "Jianxun Wang, Yue Lu, Fenghua Meng, Zhiyuan Zhong", "journal": "Biomaterials", "year": "2020", "volumes": "230", "first page": "119619", "last page": "119619", "DOI": "10.1016/j.biomaterials.2019.119619"}, {"title": "Peptide-based gene delivery systems", "authors": "Ester Vázquez, Mireia Ferrer-Miralles, Ramon Mangues, Esther Vazquez, Antonio Villaverde", "journal": "Drug Discovery Today", "year": "2008", "volumes": "13", "first page": "1067", "last page": "1074", "DOI": "10.1016/j.drudis.2008.07.010"}]}